Skip to main content
. 2012 Jan 31;2012:596029. doi: 10.5402/2012/596029

Table 1.

Comparison of patient demographics and pretreatment features.

Surgery Radiation Hormone therapy Total P value
Age <0.0011
N 216 59 129 404
 Mean (SD) 64.6 (7.2) 70.9 (8.4) 77 (8.1) 69.5 (9.5)
Race, N (%) 0.482
 White 161 (74.5) 40 (67.8) 92 (71.3) 293 (72.5)
 Black 14 (6.5) 7 (11.9) 16 (12.4) 37 (9.2)
 Other 3 (1.4) 0 (0) 1 (0.8) 4 (1)
 Unknown 38 (17.6) 12 (20.3) 20 (15.5) 70 (17.3)
 Total 216 59 129 404
Gleason score, N (%) 0.372
 8 84 (54.2) 33 (55.9) 63 (48.8) 180 (52.5)
 9 67 (43.2) 22 (37.3) 57 (44.2) 146 (42.6)
 10 4 (2.6) 4 (6.8) 9 (7) 17 (5)
 Total3 155 59 129 343
PSA at diagnosis (ng/mL) <0.0011
N 208 57 126 391
 Mean (SD) 10.3 (11.9) 15.5 (27.1) 48.2 (79.4) 23.3 (50)
Fraction of positive cores <0.0011
N 214 59 126 399
 Mean (SD) 50% (30%) 40% (30%) 60% (30%) 50% (30%)

1Kruskal-Wallis Test.

2Pearson's Chi-Square Test.

361 surgical patients had a Gleason score of <8 on biopsy but ≥8 on radical prostatectomy pathology and thus were included for analysis.